Brief: Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff To Its Board Of Directors
04/11/2024 13:29
Nov 4 (Reuters) - Actinium Pharmaceuticals Inc ATNM.A :
* ACTINIUM PHARMACEUTICALS APPOINTS ACCOMPLISHED BIOPHARMA
INDUSTRY EXECUTIVE JUNE ALMENOFF, M.D., PH.D. TO ITS BOARD OF
DIRECTORS
Source text: ID:nPnbzkfsBa
Further company coverage: ATNM.A
(Reuters.Briefs@thomsonreuters.com)
Recent news on Actinium Pharmaceuticals
See all newsBrief: Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances For Actimab-A And Iomab-Act Programs
Brief: ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS
Brief: Actinium Pharmaceuticals Says ATNM-400 Shows Superior Efficacy To Xtandi In Prostate Cancer
Brief: Actinium Pharmaceuticals Announces ATNM-400 A Novel Non-PSMA Targeting First In Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Brief: Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities